Ad
related to: fda, pharmaceuticals
Search results
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 17 hours agoCantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening ...
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Digital Journal· 20 hours ago("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and ...
Mira Pharmaceuticals progresses Ketamir-2 preclinical trials By Investing.com
Investing.com· 16 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a pre-clinical-stage pharmaceutical company, announced...
Hims & Hers to sell inexpensive Ozempic alternative
NY Daily News via Yahoo Finance· 7 hours agoOnline pharmaceutical brands Hims & Hers are introducing a weight-loss drug containing a compounded form of semaglutide, the active ingredient in...
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2,...
The Fairfax County Times· 21 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic ...
WHISTLEBLOWER ALLEGES GLAXOSMITHKLINE LIED ABOUT ZANTAC SAFETY CLAIMS
WFRV 5 Green Bay· 13 hours ago...Represented by Wisner Baum, alleges in qui tam suit that GlaxoSmithKline (GSK) lied to the FDA and Federal Government about the ability of its "blockbuster" drug to expose consumers to a potent human carcinogen, resulting...May 20, 2024 /PRNewswire/ -- Valisure LLC, a technology company that...
ILJIN SNT Co., Ltd. Calls for Board Restructure at Aurinia Pharmaceuticals
Benzinga· 8 hours ago("Aurinia" or the "Company") and has been supportive of the Company's mission since 2010 when we invested in...of the largest and longest-standing shareholders, we have had the privilege of ...
FDA rejects liver cancer drug combo, shares of Korean biotech tank
Endpoints News· 4 days agoKorean biotech HLB and its China-based partner Jiangsu Hengrui Pharmaceuticals said Friday that the ...
Compatibility issues found with autoinjectors, FDA says
Becker’s Hospital Review· 4 days agoThe FDA is warning healthcare professionals about compatibility issues between autoinjectors and glatiramer acetate injections, which are approved to treat relapsing forms ...
US FDA approves two biosimilars for blockbuster eye drug Eylea
Reuters via AOL· 18 hours agoThe agency approved Biocon Biologics' Yesafili as well as Samsung Bioepis and Biogen's Opuviz, while...
